AXT announces exercise of over-allotment option
Underwriters purchase additional 1,284,046 shares at $64.25, yielding $82.5 million gross proceeds. Funds support subsidiary capacity expansion, R&D, and working capital.
See the latest news and media coverage for AXT. We track all announcements, press releases, and industry mentions in real time, all in one place.
Manufacturer of compound and single-element semiconductor wafer substrates
axt.comLast updated
In short: AXT reported first-quarter revenue growth of nearly 39% and expanded indium phosphide capacity to support demand from AI data centers.
Underwriters purchase additional 1,284,046 shares at $64.25, yielding $82.5 million gross proceeds. Funds support subsidiary capacity expansion, R&D, and working capital.
The company intends to use proceeds to support subsidiary capacity expansion, R&D, and working capital. Underwriters get a 30-day overallotment option.
Revenue reaches $26.9 million, gross margin 29.6%, net loss $1.6 million. Raised $632.5 million for indium phosphide expansion.
Q4 revenue was $23.0M with net loss of $3.5M. FY 2025 revenue totaled $88.3M with net loss of $21.3M. CEO anticipates Q1 2026 growth.
Axt Inc stock hits 52-week low at 95.35 USD...
AXT Inc. (NasdaqGS:AXTI) reported improved first quarter results, with a smaller net loss and higher revenue. The company linked this performance to rising demand from...
AXT Inc. (NASDAQ:AXTI) is one of the 10 Stocks Effortlessly Climbing Double-Digits. AXT Inc. soared to a fresh all-time high on Friday, as investors resumed...
AXT Inc () has held its Q1 earnings call. Read on for the main highlights of the call. Meet Samuel - Your Personal Investing Prophet...
Track AXT and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to AXT and other trending companies.